New treatments for rare diseases
Research improving outcomes for patients.
Driving impact for rare disease patients
Millions of people live with rare diseases, yet most conditions still have no approved treatment. Through NE BRIDGE, we’re speeding up the development of new therapies. We bring together research, healthcare, industry, and artificial intelligence to improve outcomes for patients across the UK and beyond.
The challenge for rare disease patients
Rare diseases affect around 160,000 people in the North East and 3.5 million across the UK.
Each condition is uncommon, but together they form one of the largest areas of unmet need in healthcare. Many patients wait years for a diagnosis. Treatment options are limited. 95% of rare diseases still have no approved therapy.
To help meet this need, we’re leading NE BRIDGE, an ambitious platform designed to speed up the journey from discovery to patient care.
.jpg)
The future of healthcare depends on turning scientific breakthroughs into real-world treatments for patients.
NE BRIDGE and collaborative change
NE BRIDGE brings together leading researchers, the NHS, and industry partners. The aim is to create a coordinated approach to rare disease innovation. The programme tackles one of the greatest barriers in healthcare: transforming promising discoveries into treatments that reach patients.
By linking expertise across the full development pathway, from diagnosis and discovery to clinical trials and commercialisation, NE BRIDGE will help promising therapies progress more efficiently towards patient benefit.
The North East is uniquely placed to deliver this vision. The region has internationally-recognised expertise in rare diseases, a large patient population, world-class NHS clinical and trial infrastructure, and a growing life sciences sector. These strengths create one of the UK's most integrated ecosystems for rare disease research and therapeutic development.
A key feature of NE BRIDGE is the use of advanced artificial intelligence through the National Innovation Centre for Data. By analysing large-scale clinical, biological and real-world datasets, AI will help identify therapeutic opportunities, prioritise development programmes, and reduce the time and cost of bringing treatments to patients.
Truly transformative impact for patients
Alongside health benefits, NE BRIDGE will attract investment, support life sciences companies, create highly-skilled jobs and strengthen the North East's reputation for scientific excellence and healthcare innovation.
The future of rare disease innovation
NE BRIDGE is building a new model for rare disease innovation. It brings together world-leading research, clinical excellence, industry collaboration, and artificial intelligence to accelerate progress in ways that really matter.
Although rooted in Newcastle, NE BRIDGE is designed as a national asset with global potential. It will improve outcomes for patients across the UK and help establish the region as a world-leading centre in rare disease research, translation, and healthcare innovation.